الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
81 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Dr. Maged Abdelfatah Amine Hassan 2021
82 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
83 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Mayada Fawzy Sedik Farghaly 2021
84 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Prof. Ashraf Zeidan Abdalla Ahmed 2020
85 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Rabab Mohammed Mamdouh Abdelhameed 2020
86 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Sanaa Saber Abdelraheem Barakat 2020
87 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Matta Gerges Mounir Meshreky 2020
88 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Mayada Fawzy Sedik Farghaly 2020
89 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
 		Dr. Hanaan Ahmed Mohammed Ahmed 2020
90 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2020